+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

US Market Overview for Interventional Cardiology 2018 - MedView

  • PDF Icon

    Report

  • March 2018
  • Region: United States
  • iData Research
  • ID: 4482833
Following several years of substantial declines, percutaneous coronary intervention (PCI) procedure volume has recently stabilized, and is expected to grow at low single digits over the forecast period. Procedure growth exhibits a positive effect on the associated device markets, such as stents, balloon catheters, interventional catheters and guidewires and various other devices required per procedure. Angiography procedure volume is also expected to remain stable over the forecast period.

Table of Contents

EXECUTIVE SUMMARY
U.S. INTERVENTIONAL CARDIOLOGY DEVICE MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
PROCEDURE CODES INVESTIGATED
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY

1. RESEARCH METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecasts and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring

2. DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.2 DISEASE TREATMENTS AND DIAGNOSTICS
2.2.1 General Diagnostics
2.2.2 Coronary Artery Disease (CAD)
2.2.3 Myocardial Infarction (MI)
2.2.4 Angina Pectoris
2.3 PATIENT DEMOGRAPHICS
2.3.1 General Statistics

3. BALLOON-INFLATION DEVICE MARKET
3.1 INTRODUCTION
3.2 MARKET ANALYSIS AND FORECAST
3.3 DRIVERS AND LIMITERS
3.3.1 Market Drivers
3.3.2 Market Limiters
3.4 COMPETITIVE MARKET SHARE ANALYSIS

ABBREVIATIONS

APPENDIX I: COMPANY PRESS RELEASES

List of Charts
Chart 1 1: Interventional Cardiology Device Market by Segment, U.S., 2014 – 2024
Chart 1 2: Interventional Cardiology Device Market Overview, U.S., 2017 & 2024
Chart 3 1: Balloon-Inflation Device Market, U.S., 2014 – 2024
Chart 3 2: Leading Competitors, Balloon-Inflation Device Market, U.S., 2017

List of Figures:
Figure 1 1: Interventional Cardiology Device Market Share Ranking by Segment, U.S., 2017 (1 of 3)
Figure 1 2: Interventional Cardiology Device Market Share Ranking by Segment, U.S., 2017 (2 of 3)
Figure 1 3: Interventional Cardiology Device Market Share Ranking by Segment, U.S., 2017 (3 of 3)
Figure 1 4: Companies Researched in this Report, U.S., 2017
Figure 1 5: Factors Impacting the Interventional Cardiology Market by Segment, U.S. (1 of 3)
Figure 1 6: Factors Impacting the Interventional Cardiology Market by Segment, U.S. (2 of 3)
Figure 1 7: Factors Impacting the Interventional Cardiology Market by Segment, U.S. (3 of 3)
Figure 1 8: Recent Events in the Interventional Cardiology Market, U.S., 2014 – 2017
Figure 1 9: Interventional Cardiology Procedures Covered, U.S., 2017
Figure 1 10: Procedure Codes Investigated, U.S., 2017
Figure 1 11: Interventional Cardiology Markets Covered, U.S., 2017 (1 of 2)
Figure 1 12: Interventional Cardiology Markets Covered, U.S., 2017 (2 of 2)
Figure 1 13: Key Report Updates
Figure 1 14: Version History
Figure 3 1: Balloon-Inflation Device Market, U.S., 2014 – 2024
Figure 3 2: Drivers and Limiters, Balloon-Inflation Device Market, U.S., 2017
Figure 3 3: Leading Competitors, Balloon-Inflation Device Market, U.S., 2017
Figure 5 1: Press Release Summary

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Boston Scientific

  • Abbott Laboratories

  • Medtronic

  • Philips

  • Terumo

  • Cardinal Health

  • Merit Medical Systems

  • Cook Medical

  • Asahi Intecc

  • Teleflex

  • Cardiovascular Systems Inc.

  • Galt Medical

  • C.R. Bard

  • Angiodynamics

  • ACIST Medical Systems

  • Infraredx

  • Tryton Medical

  • B. Braun

  • Maquet


Please Note: Not all companies are currently active in every segment or sub-report from this suite.